Mihael H. Polymeropoulos - Feb 16, 2024 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: President and CEO, Director, Chairman of the Board
Signature: /s/ Mihael Polymeropoulos
Stock symbol: VNDA
Transactions as of: Feb 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/21/2024, 04:52 PM
Previous filing: Mar 6, 2023
Next filing: Mar 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Award	$0	+450K	+30.47%	$0.00	1.93M	Feb 16, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2025, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Content

Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2025, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.